Bartlett & Co Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.6K | Sell |
927
-95
| -9% | -$10.2K | ﹤0.01% | 544 |
|
|
2025
Q1 | $103K | Sell |
1,022
-316
| -24% | -$31.9K | ﹤0.01% | 542 |
|
|
2024
Q4 | $120K | Hold |
1,338
| – | – | ﹤0.01% | 516 |
|
|
2024
Q3 | $112K | Hold |
1,338
| – | – | ﹤0.01% | 528 |
|
|
2024
Q2 | $103K | Buy |
1,338
+31
| +2% | +$2.39K | ﹤0.01% | 538 |
|
|
2024
Q1 | $89.5K | Buy |
1,307
+59
| +5% | +$4.04K | ﹤0.01% | 578 |
|
|
2023
Q4 | $70.2K | Hold |
1,248
| – | – | ﹤0.01% | 636 |
|
|
2023
Q3 | $65.9K | Buy |
1,248
+758
| +155% | +$40K | ﹤0.01% | 610 |
|
|
2023
Q2 | $26.5K | Hold |
490
| – | – | ﹤0.01% | 770 |
|
|
2023
Q1 | $24.5K | Hold |
490
| – | – | ﹤0.01% | 680 |
|
|
2022
Q4 | $22.7K | Hold |
490
| – | – | ﹤0.01% | 702 |
|
|
2022
Q3 | $19K | Sell |
490
-49
| -9% | -$1.9K | ﹤0.01% | 715 |
|
|
2022
Q2 | $20.1K | Buy |
539
+217
| +67% | +$8.09K | ﹤0.01% | 739 |
|
|
2022
Q1 | $14.3K | Buy |
+322
| New | +$14.3K | ﹤0.01% | 780 |
|
|
2021
Q4 | – | Sell |
-322
| Closed | -$14K | – | 469 |
|
|
2021
Q3 | $14K | Sell |
322
-33
| -9% | -$1.43K | ﹤0.01% | 670 |
|
|
2021
Q2 | $15.2K | Hold |
355
| – | – | ﹤0.01% | 653 |
|
|
2021
Q1 | $13.7K | Hold |
355
| – | – | ﹤0.01% | 702 |
|
|
2020
Q4 | $12.8K | Buy |
355
+33
| +10% | +$1.19K | ﹤0.01% | 707 |
|
|
2020
Q3 | $12.3K | Hold |
322
| – | – | ﹤0.01% | 663 |
|
|
2020
Q2 | $11.3K | Hold |
322
| – | – | ﹤0.01% | 667 |
|
|
2020
Q1 | $10.5K | Hold |
322
| – | – | ﹤0.01% | 654 |
|
|
2019
Q4 | $14.6K | Hold |
322
| – | – | ﹤0.01% | 690 |
|
|
2019
Q3 | $13.1K | Buy |
+322
| New | +$13.1K | ﹤0.01% | 707 |
|
|
2019
Q2 | – | Sell |
-27
| Closed | -$1.04K | – | 772 |
|
|
2019
Q1 | $1.04K | Buy |
+27
| New | +$1.04K | ﹤0.01% | 680 |
|